PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14962259-10	2004	Among five patients with low beta(2) microglobulin and normal chromosome 13q, four patients achieved a CR, with CR duration >5 yr in three of them.	Chromium	103-105	beta-2-microglobulin	Homo sapiens	29-50	
19704063-9	2009	Advanced clinical stage, del(17p), or increased serum beta2-microglobulin levels correlated with a lower CR rate.	Chromium	105-107	beta-2-microglobulin	Homo sapiens	54-73	
19387524-5	2009	The urinary mercury and urinary beta(2)-microglobulin for the residents living in the contaminated area were 1.24 +/- 3.80 microg/L and 228.98 +/- 4.34 microg/g Cr, higher than those in the non-mercury contaminated area.	Chromium	161-163	beta-2-microglobulin	Homo sapiens	32-53	
17897640-4	2008	The average urinary beta2-microglobulin (beta2-MG) was 248 microg/g Cr for the exposed group contrasting to 73.5 microg/g Cr for the control group and the data showed a serious adverse effect on renal system for the smelting workers.	Chromium	68-70	beta-2-microglobulin	Homo sapiens	20-39	
17897640-4	2008	The average urinary beta2-microglobulin (beta2-MG) was 248 microg/g Cr for the exposed group contrasting to 73.5 microg/g Cr for the control group and the data showed a serious adverse effect on renal system for the smelting workers.	Chromium	68-70	beta-2-microglobulin	Homo sapiens	41-49	
15692680-2	2005	The urinary ratio of beta2-microglobulin and creatinine (beta2M/Cr) was very high in a transplanted woman with nephrocalcinosis (> 3.23 mg/mmol) and slightly high in five patients (> 0.052 or < 1.0 mg/mmol) with multiple urological manipulations.	Chromium	64-66	beta-2-microglobulin	Homo sapiens	21-40	
14962259-10	2004	Among five patients with low beta(2) microglobulin and normal chromosome 13q, four patients achieved a CR, with CR duration >5 yr in three of them.	Chromium	112-114	beta-2-microglobulin	Homo sapiens	29-50	
2006396-1	1991	The purpose of this prospective study was to evaluate beta-2-microglobulin (beta 2m) as a differential diagnostic indicator between hepatic nephropathy (HN) and acute tubulointerstitial nephropathy (ATIN) in patients with reduced renal function and hepatic coma, and to determine whether beta 2m excretion could be used as a marker of renal impairment before increased serum creatinine (S-Cr) concentration or decreased creatinine clearance (Cr-Cl).	Chromium	389-391	beta-2-microglobulin	Homo sapiens	54-74	
1411368-3	1992	Beta 2-microglobulin was slightly increased in those welders with a urinary chromium concentration of greater than 64.5 nmol.mmol-1 creatinine.	Chromium	76-84	beta-2-microglobulin	Homo sapiens	0-20	
1289022-3	1992	In RBP-negative patients, the subjects with hypertension (systolic blood pressure > or = 140 mmHg or diastolic blood pressure > or = 90 mmHg) showed higher beta 2-microglobulin (beta 2-MG) excretion and albumin (Alb)/Cr ratios than normotensive ones.	Chromium	223-225	beta-2-microglobulin	Homo sapiens	162-182	
2006396-1	1991	The purpose of this prospective study was to evaluate beta-2-microglobulin (beta 2m) as a differential diagnostic indicator between hepatic nephropathy (HN) and acute tubulointerstitial nephropathy (ATIN) in patients with reduced renal function and hepatic coma, and to determine whether beta 2m excretion could be used as a marker of renal impairment before increased serum creatinine (S-Cr) concentration or decreased creatinine clearance (Cr-Cl).	Chromium	389-391	beta-2-microglobulin	Homo sapiens	76-83	
33713715-8	2021	With respect to Cd and to some extent Cr, beta-2-microglobulin (B2-MG) and N-acetyl-beta-D-glucosaminidase (NAG) are well-established, sensitive, and the most common effect biomarkers to relate Cd or Cr exposure to renal tubular dysfunction.	Chromium	200-202	beta-2-microglobulin	Homo sapiens	42-62	
33713715-8	2021	With respect to Cd and to some extent Cr, beta-2-microglobulin (B2-MG) and N-acetyl-beta-D-glucosaminidase (NAG) are well-established, sensitive, and the most common effect biomarkers to relate Cd or Cr exposure to renal tubular dysfunction.	Chromium	38-40	beta-2-microglobulin	Homo sapiens	42-62	
31200147-8	2019	In a univariate analysis, platelet count and B2M level at diagnosis were statistically associated with CR achievement (p = 0.004 and p = 0.024, respectively).	Chromium	103-105	beta-2-microglobulin	Homo sapiens	45-48	
25577449-6	2015	The present study demonstrated that even if the patient is in CR before ASCT if he has high beta2m, the 2-year OS decreases from 100% to 49%.	Chromium	62-64	beta-2-microglobulin	Homo sapiens	92-98	
20717692-8	2011	Exposure to Cr seems to induce an enhanced level of urinary NAG activity and beta(2)M concentration.	Chromium	12-14	beta-2-microglobulin	Homo sapiens	77-85